| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |